+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nano Urea - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6106104
The global market for Nano Urea was valued at US$194.1 Million in 2025 and is projected to reach US$898.6 Million by 2032, growing at a CAGR of 24.5% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Nano Urea Market - Key Trends & Drivers Summarized

Why Is Nano Urea Emerging as a Disruptive Input in Sustainable Agriculture?

Nano urea is a liquid fertilizer developed using nanotechnology to improve nitrogen delivery to crops with significantly lower application volumes compared to conventional urea. Traditional urea is known to suffer from inefficiencies due to leaching, volatilization, and runoff, resulting in nutrient loss and environmental damage. Nano urea addresses these challenges by enhancing nitrogen uptake efficiency at the foliar level, reducing application frequency while maintaining or improving crop yields.

Its introduction aligns with global efforts to reduce chemical fertilizer dependency, minimize ecological harm, and optimize input costs in farming. By enabling targeted delivery at the cellular level, nano urea reduces the total amount of nitrogen needed per hectare. This contributes to better soil health, reduced greenhouse gas emissions, and improved water retention in agricultural ecosystems. Its adoption is particularly relevant in regions facing fertilizer shortages or strict environmental regulations.

How Is Technology Enhancing Efficacy and Application of Nano Urea?

Nano urea is manufactured using a process that involves coating nitrogen particles with nanoscale carriers to control their release and absorption. These nano-sized particles exhibit higher surface area, allowing faster and more uniform foliar absorption through stomata on plant leaves. Unlike bulk urea, which is applied to soil, nano urea is sprayed directly onto plant surfaces, bypassing traditional routes of nutrient loss.

The formulation is typically water-based, non-toxic, and free from heavy metal residues, ensuring compatibility with organic and precision farming practices. Spray-based application ensures even coverage and rapid action. As digital farming technologies evolve, nano urea is being integrated with drone spraying systems, enabling farmers to optimize dosage across different field zones. Storage and transportation costs are also lower due to its compact liquid form, offering logistical advantages over bulk granular fertilizers.

Which Regions and Crop Systems Are Driving Adoption of Nano Urea?

Adoption is accelerating in agriculture-intensive countries seeking to enhance crop productivity while controlling input costs and pollution. Regions with fragmented land holdings and low fertilizer-use efficiency are early adopters, particularly in Asia. Governments and cooperatives are promoting nano urea through pilot programs, subsidies, and farmer training initiatives. Cereal crops like wheat, rice, and maize are key focus areas due to their high nitrogen demand and scale of cultivation.

Horticultural crops, oilseeds, and pulses are also increasingly using nano urea for foliar feeding. Smallholder farmers benefit from its portability, ease of use, and reduced application requirements. Large-scale commercial farms exploring climate-resilient practices are testing nano urea as part of integrated nutrient management systems. Demand is also rising in regions with strict environmental oversight, where nutrient runoff limits are pushing a shift toward more efficient fertilizer practices.

Growth in the Nano Urea Market Is Driven by Several Factors

Growth in the nano urea market is driven by several factors. Rising need for sustainable, efficient nitrogen fertilizers supports demand among farmers and policy makers. Increased awareness of soil degradation and fertilizer overuse prompts interest in alternatives with lower environmental impact. Advancements in nanotechnology enable precise formulation and consistent performance under diverse crop conditions. Expansion of drone-based and precision agriculture practices encourages foliar applications of liquid fertilizers. Public sector support through regulatory approvals, incentives, and demonstration projects accelerates commercialization. Finally, the cost savings from reduced fertilizer volumes, combined with improved yield outcomes, are encouraging wider adoption of nano urea in both conventional and progressive farming systems.

Report Scope

The report analyzes the Nano Urea market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: End-Use (Food Crops End-Use, Cash Crops End-Use, Horticulture Crops End-Use, Plantation Crops End-Use, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Food Crops End-Use segment, which is expected to reach US$357.8 Million by 2032 with a CAGR of a 24.7%. The Cash Crops End-Use segment is also set to grow at 21.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $52.9 Million in 2025, and China, forecasted to grow at an impressive 31.2% CAGR to reach $217.6 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nano Urea Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nano Urea Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nano Urea Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Aries Agro Limited, BASF SE, CF Industries Holdings, Inc., Chambal Fertilizers & Chemicals Ltd, Coromandel International Limited and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Nano Urea market report include:

  • Aries Agro Limited
  • BASF SE
  • CF Industries Holdings, Inc.
  • Chambal Fertilizers & Chemicals Ltd
  • Coromandel International Limited
  • Deepak Fertilizers & Petrochemicals Corp Ltd
  • Fertilizers and Chemicals Travancore Ltd (FACT)
  • Gujarat State Fertilizers & Chemicals Ltd
  • Hindustan Insecticides Ltd
  • IFFCO (Indian Farmers Fertiliser Cooperative Ltd)
  • Krishak Bharati Cooperative Ltd (KRIBHCO)
  • Mangalore Chemicals & Fertilizers Ltd
  • Mosaic Company
  • National Fertilizers Limited
  • Nagarjuna Fertilizers & Chemicals Ltd
  • Nufarm Limited
  • Nutrien Ltd.
  • Rashtriya Chemicals & Fertilizers Ltd (RCF)
  • Southern Petrochemical Industries Corporation Ltd (SPIC)
  • Tata Chemicals Limited
  • Yara International ASA
  • Qatar Fertiliser Company (QAFCO)

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Nanobodies - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Targeted and Versatile Biotherapeutics Drives Interest in Nanobody-Based Drug Development
  • Superior Stability and Smaller Molecular Size of Nanobodies Throws Spotlight on Their Use in Hard-to-Reach Targets
  • Advancements in Immunotherapy and Oncology Research Propel Adoption of Nanobody-Based Modalities
  • Expansion of Bispecific and Multivalent Therapeutics Supports Use of Nanobodies in Complex Drug Design
  • Growing Research Activity in Autoimmune and Inflammatory Diseases Enhances Scope for Nanobody Applications
  • Increased Use of Nanobodies in Diagnostic Imaging and Molecular Tracers Strengthens Demand in Precision Medicine
  • OEM Collaborations With Academic Institutions Accelerate Innovation in Rare and Orphan Disease Therapeutics
  • Favorable Pharmacokinetics and Reduced Immunogenicity Drive Preference Over Conventional Antibodies
  • Emerging Interest in Inhalable and Topical Drug Delivery Formats Fuels Development of Nanobody-Based Treatments
  • Growth in CNS and Blood-Brain Barrier Research Encourages Nanobody Use for Neurological Conditions
  • Vaccine Development and Viral Neutralization Studies Highlight Role of Nanobodies in Infectious Disease Management
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Nanobodies Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Nanobodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Nanobodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Nanobodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Mono-Specific Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Mono-Specific Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Mono-Specific Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Multi-Specific Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Multi-Specific Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Multi-Specific Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Acquired Thrombotic Thrombocytopenic Purpura Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Acquired Thrombotic Thrombocytopenic Purpura Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Acquired Thrombotic Thrombocytopenic Purpura Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Respiratory Syncytial Virus Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Respiratory Syncytial Virus Infection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Rheumatoid Arthritis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Rheumatoid Arthritis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Systemic Lupus Erythematosus Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Systemic Lupus Erythematosus Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Systemic Lupus Erythematosus Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Psoriasis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Psoriasis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Psoriasis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Bone Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Bone Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Bone Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Nanobodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aries Agro Limited
  • BASF SE
  • CF Industries Holdings, Inc.
  • Chambal Fertilizers & Chemicals Ltd
  • Coromandel International Limited
  • Deepak Fertilizers & Petrochemicals Corp Ltd
  • Fertilizers and Chemicals Travancore Ltd (FACT)
  • Gujarat State Fertilizers & Chemicals Ltd
  • Hindustan Insecticides Ltd
  • IFFCO (Indian Farmers Fertiliser Cooperative Ltd)
  • Krishak Bharati Cooperative Ltd (KRIBHCO)
  • Mangalore Chemicals & Fertilizers Ltd
  • Mosaic Company
  • National Fertilizers Limited
  • Nagarjuna Fertilizers & Chemicals Ltd
  • Nufarm Limited
  • Nutrien Ltd.
  • Rashtriya Chemicals & Fertilizers Ltd (RCF)
  • Southern Petrochemical Industries Corporation Ltd (SPIC)
  • Tata Chemicals Limited
  • Yara International ASA
  • Qatar Fertiliser Company (QAFCO)

Table Information